Open Label Trial of Therapeutic Vaccine in Patients With Cholangiocarcinoma

Status: Recruiting

Phase of Trial: Phase I/II

Latest Information Update: 05 Nov 2021

Price : $35 ^*

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs V3-X (Primary)
Indications Cholangiocarcinoma
Focus Therapeutic Use
Acronyms cholangio
Sponsors Immunitor

Most Recent Events

29 Aug 2019 Planned End Date changed from 20 Apr 2019 to 20 Apr 2020.
29 Aug 2019 Planned primary completion date changed from 20 Feb 2019 to 20 Feb 2020.
08 Feb 2017 New trial record

Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

IP authentication when working within your organization’s network.
Login with username/password or try access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days.
Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

Contact your organization’s admin about adding this content to your AdisInsight subscription
Buy a PDF version of the profile.
Request a free trial

Welcome to AdisInsight